Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Metagenomi Inc’s stock clocked out at $2.76, down -5.15% from its previous closing price of $2.91. In other words, the price has decreased by -$5.15 from its previous closing price. On the day, 0.5 million shares were traded. MGX stock price reached its highest trading level at $2.97 during the session, while it also had its lowest trading level at $2.67.
Ratios:
To gain a deeper understanding of MGX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.18 and its Current Ratio is at 6.18. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on May 07, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
On May 02, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $16 to $6.
On March 05, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $25.Wells Fargo initiated its Overweight rating on March 05, 2024, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 05 ’24 when Wapnick Pamela sold 1,559 shares for $1.86 per share. The transaction valued at 2,900 led to the insider holds 61,492 shares of the business.
Wapnick Pamela sold 6,265 shares of MGX for $18,043 on Sep 05 ’24. The Chief Financial Officer now owns 63,051 shares after completing the transaction at $2.88 per share. On Feb 13 ’24, another insider, Novo Holdings A/S, who serves as the 10% Owner of the company, bought 800,000 shares for $15.00 each. As a result, the insider paid 12,000,000 and bolstered with 1,739,175 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGX now has a Market Capitalization of 103289960 and an Enterprise Value of -125223992. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.88 while its Price-to-Book (P/B) ratio in mrq is 0.40. Its current Enterprise Value per Revenue stands at -2.273 whereas that against EBITDA is 1.503.
Stock Price History:
Over the past 52 weeks, MGX has reached a high of $12.74, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 0.76%, while the 200-Day Moving Average is calculated to be -34.75%.
Shares Statistics:
It appears that MGX traded 1.91M shares on average per day over the past three months and 775190 shares per day over the past ten days. A total of 37.43M shares are outstanding, with a floating share count of 18.78M. Insiders hold about 49.81% of the company’s shares, while institutions hold 24.79% stake in the company. Shares short for MGX as of 1735603200 were 2045705 with a Short Ratio of 1.07, compared to 1732838400 on 271482. Therefore, it implies a Short% of Shares Outstanding of 2045705 and a Short% of Float of 7.5600000000000005.
